| Literature DB >> 32149355 |
M Osman Sheikh1, David Venzke2, Mary E Anderson2, Takako Yoshida-Moriguchi2, John N Glushka1, Alison V Nairn1, Melina Galizzi1, Kelley W Moremen1,3, Kevin P Campbell2, Lance Wells1,3.
Abstract
Mutations in multiple genes required for proper O-mannosylation of α-dystroglycan are causal for congenital/limb-girdle muscular dystrophies and abnormal brain development in mammals. Previously, we and others further elucidated the functional O-mannose glycan structure that is terminated by matriglycan, [(-GlcA-β3-Xyl-α3-)n]. This repeating disaccharide serves as a receptor for proteins in the extracellular matrix. Here, we demonstrate in vitro that HNK-1 sulfotransferase (HNK-1ST/carbohydrate sulfotransferase) sulfates terminal glucuronyl residues of matriglycan at the 3-hydroxyl and prevents further matriglycan polymerization by the LARGE1 glycosyltransferase. While α-dystroglycan isolated from mouse heart and kidney is susceptible to exoglycosidase digestion of matriglycan, the functional, lower molecular weight α-dystroglycan detected in brain, where HNK-1ST expression is elevated, is resistant. Removal of the sulfate cap by a sulfatase facilitated dual-glycosidase digestion. Our data strongly support a tissue specific mechanism in which HNK-1ST regulates polymer length by competing with LARGE for the 3-position on the nonreducing GlcA of matriglycan.Entities:
Keywords: O-mannosylation; congenital muscular dystrophy; glycosylation; sulfotransferase; α-dystroglycan
Year: 2020 PMID: 32149355 PMCID: PMC7673472 DOI: 10.1093/glycob/cwaa024
Source DB: PubMed Journal: Glycobiology ISSN: 0959-6658 Impact factor: 4.313